Show simple item record

Rib infarcts and acute chest syndrome in sickle cell diseases

dc.contributor.authorRucknagel, Donald L.en_US
dc.contributor.authorRucknagel, Donald L.en_US
dc.contributor.authorKalkinyak, K. A.en_US
dc.contributor.authorGelfand, M. J.en_US
dc.date.accessioned2006-04-10T14:45:26Z
dc.date.available2006-04-10T14:45:26Z
dc.date.issued1991-04-06en_US
dc.identifier.citationRucknagel, D. L., Rucknagel, D. L., Kalkinyak, K. A., Gelfand, M. J. (1991/04/06)."Rib infarcts and acute chest syndrome in sickle cell diseases." The Lancet 337(8745): 831-833. <http://hdl.handle.net/2027.42/29382>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T1B-49K576Y-126/2/e3d7e9d6372a04f5f3d648ffe1419794en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/29382
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1672922&dopt=citationen_US
dc.description.abstractIn the absence of evidence for pneumonia or pulmonary embolus, primary pulmonary infarction has been assumed to be the cause of the syndrome of chest pain, fever, and pulmonary infiltrate on chest X-ray that commonly complicates sickle cell anaemia. To find out whether the syndrome might be due to rib infarction, 99mTc-diphosphonate bone scans were done. In the eleven episodes thus investigated (10 patients) the scans showed segmental areas of increased radionuclide uptake in ribs, indicative of bone infarction. A possible sequence of events is that the rib infarcts are primary and cause bone pain, followed by soft tissue reaction, pleuritis, and splinting. The resultant hypoventilation leads to atelectasis and subsequent development of the radiographic changes of the acute chest syndrome. Prevention of hypoventilation and treatment of bone pain are important therapeutic goals.en_US
dc.format.extent716057 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleRib infarcts and acute chest syndrome in sickle cell diseasesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Human Genetics and Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United Statesen_US
dc.contributor.affiliationotherComprehensive Sickle Cell Centre, Children's Hospital Medical Center, Elland and Bethesda Aves, Cincinnati, Ohio, United Statesen_US
dc.contributor.affiliationotherComprehensive Sickle Cell Centre, Children's Hospital Medical Center, Elland and Bethesda Aves, Cincinnati, Ohio, United Statesen_US
dc.contributor.affiliationotherDivision of Radiology, Children's Hospital Medical Center, and Radioiostope Laboratory, Department of Radiology, University of Cincinnati, Cincinnati, Ohio, United Statesen_US
dc.identifier.pmid1672922en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/29382/1/0000452.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0140-6736(91)92525-7en_US
dc.identifier.sourceThe Lanceten_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.